C.R. Bard Inc. lost its appeal of a jury’s $2 million verdict in a bellwether trial that found the medical device maker liable for a woman’s injuries from defective vaginal mesh implants whe... Read more
Blood clots that develop in the legs, called deep vein thrombosis (DVT), can cause serious complications. Typically, doctors treat DVTs with anticoagulant medications (sometimes called blood... Read more
Major activity is underway in the seven transvaginal mesh multidistrict litigations in the Southern District of West Virginia. While American Medical Systems (AMS) continues to settle claims... Read more
U.S. District Judge Joseph R. Goodwin has ruled in favor of the Plaintiff in allowing a $2 million verdict against transvaginal mesh manufacturer C.R. Bard to stand. The jury verdict was han... Read more
To date, more than 30,000 transvaginal mesh (TVM) lawsuits have been filed in the U.S. District Court for the Southern District of West Virginia as part of ongoing Multidistrict Litigation (... Read more
Shortly after the Cisson trial, C.R. Bard reached a settlement in the second bellwether case in multidistrict litigation (MDL) over the company’s defective vaginal mesh implants. This... Read more
A West Virginia federal jury has found C.R. Bard Inc. responsible for injuries a woman suffered from a defective vaginal mesh implant. The jurors returned a $2 million verdict against Bard i... Read more
On July 8 the United States District Court in West Virginia began the first bellwether trial in the C.R. Bard, Inc. Multidistrict Litigation (MDL). Bard is a manufacturer of transvaginal mes... Read more
The recent jury award totaling $11.1 million for Linda Gross, a transvaginal mesh Plaintiff, gives hope to the hundreds of Plaintiffs with Avaulta lawsuits. It also will have an effect on th... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.